Status:
COMPLETED
Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA
Lead Sponsor:
Taichung Veterans General Hospital
Conditions:
Nasopharyngeal Carcinoma
EBV Related Carcinoma
Eligibility:
All Genders
20-80 years
Brief Summary
No previous study reported the treatment outcome of stage III nasopharyngeal carcinoma (NPC) patients. The investigators try to investigate the long-term treatment outcome of stage III NPC patients an...
Detailed Description
The stage III NPC patients were the majority group of the patient population of NPC. But most clinical trials focused on the treatment of American Joint Committee on Cancer (AJCC) 7th edition stage IV...
Eligibility Criteria
Inclusion
- Biopsy-proven stage III nasopharyngeal carcinoma (NPC)
- Finished curative chemoradiotherapy
- Have Pre-treatment and post-radiotherapy plasma EBV DNA
Exclusion
- No tissue proven NPC
- Not finished curative treatment
- No Pre-treatment and post- radiotherapy plasma EBV DNA
Key Trial Info
Start Date :
May 2 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2016
Estimated Enrollment :
366 Patients enrolled
Trial Details
Trial ID
NCT03314051
Start Date
May 2 2012
End Date
December 31 2016
Last Update
October 20 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.